ici 204,219 has been researched along with Adenocarcinoma of Lung in 1 studies
zafirlukast: a leukotriene D4 receptor antagonist
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
Excerpt | Relevance | Reference |
---|---|---|
"Lung cancer has the highest mortality among cancers worldwide due to its high incidence and lack of the effective cures." | 1.72 | Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity. ( An, H; Li, G; Liu, W; Ma, B; Qu, C; Shi, D; Shi, S; Sun, F; Zhang, H, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Shi, S | 1 |
Ma, B | 1 |
Sun, F | 1 |
Qu, C | 1 |
Li, G | 1 |
Shi, D | 1 |
Liu, W | 1 |
Zhang, H | 1 |
An, H | 1 |
1 other study available for ici 204,219 and Adenocarcinoma of Lung
Article | Year |
---|---|
Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity.
Topics: Adenocarcinoma of Lung; Animals; Anoctamin-1; Chloride Channels; Indoles; Lung Neoplasms; Mice; Phen | 2022 |